<DOC>
	<DOCNO>NCT02527343</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety volanesorsen ( IONIS-APOCIIIRx ) give 52 week patient Familial Partial Lipodystrophy .</brief_summary>
	<brief_title>The BROADEN Study : A Study Volanesorsen ( Formerly ISIS-APOCIIIRx ) Patients With Familial Partial Lipodystrophy</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Lipodystrophy , Familial Partial</mesh_term>
	<criteria>Clinical diagnosis FPL plus diagnosis type 2 diabetes mellitus hypertriglyceridemia . Diagnosis FLP base deficiency subcutaneous body fat partial fashion assess physical examination low skinfold thickness anterior thigh caliper measurement : men ( ≤ 10 mm ) woman ( ≤ 22 mm ) , least 1 follow : Genetic diagnosis familial PL ( e.g. , mutation LMNA , PPARγ , AKT2 , CIDEC , PLIN1 gene ) OR Family history FPL family history abnormal similar fat distribution plus 1 Minor Criteria OR 2 Minor Criteria ( In absence FPLassociated genetic variant family history ) BMI &lt; 35 kg/m2 Minor Criteria 1 . Requirement high dos insulin , e.g. , require ≥ 200 U/day , ≥ 2 U/kg/day , currently take U500 insulin 2 . Presence acanthosis nigricans physical examination 3 . Evidence/history polycystic ovary syndrome ( PCOS ) PCOSlike symptom ( hirsutism , oligomenorrhea , and/or polycystic ovary ) 4 . History pancreatitis associate hypertriglyceridemia 5 . Evidence nonalcoholic fatty liver disease Hepatomegaly and/or elevate transaminase absence know cause liver disease radiographic evidence hepatic steatosis ( e.g. , ultrasound CT ) Diagnosis Type 2 diabetes mellitus define American Diabetes Association Standards Medical Care Diabetes 2015 ) make least 12 week prior Screening visit , 2 following : standardofcare antidiabetic therapy , HbA1c ≥ 7 % ≤ 10 % Screening . Hypertriglyceridemia define Fasting TG level ≥ 500 mg/dL ( ≥ 5.7 mmol/L ) Screening Qualification visit . If fast TG value Screening and/or Qualification visit &lt; 500 mg/dL ( &lt; 5.7 mmol/L ) ≥ 350 mg/dL ( ≥ 4.0 mmol/L ) 2 additional test may perform order qualify A diagnosis generalize lipodystrophy A diagnosis acquire partial lipodystrophy Acute pancreatitis within 4 week Screening History within 6 month Screening acute unstable cardiac ischemia ( myocardial infarction , acute coronary syndrome , new onset angina ) , stroke , transient ischemic attack , unstable congestive heart failure require change medication Major surgery within 3 month Screening Treatment Metreleptin within last 3 month prior Screening Previous treatment ISISAPOCIIIRx</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>